Clinical trial
DE-117 Spectrum 5 Study
NCT03697811
Study timeline
Study start (actual)2018-09-27Date precision: day
Registry last updated2023-08-30
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Interventions
Sponsors & collaborators
Santen Inc.lead sponsor
Mapped research locations
MemphisTennessee, United States2New YorkNew York, United States1St LouisMissouri, United States1San AntonioTexas, United States1NashvilleTennessee, United States1ClevelandOhio, United States1CincinnatiOhio, United States1AustinTexas, United States1RochesterNew York, United States1CharlotteNorth Carolina, United States1TulsaOklahoma, United States1Newport BeachCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03697811 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.